Details for High Impact Journal

Superfund Research Program

Nature Reviews Endocrinology (impact factor: 43.330)

2022

• Tamaki N, Ajmera VH, Loomba R. 2022. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nat Rev Endocrinol 18:doi:10.1038/s41574-021-00584-0 PMID:34815553 PMCID:PMC9012520

2020

• La Merrill MA, Vandenberg LN, Smith MT, Goodson III WH, Browne P, Patisaul HB, Guyton KZ, Kortenkamp A, Cogliano VJ, Woodruff TJ, Rieswijk L, Sone H, Korach KS, Gore AC, Zeise L, Zoeller RT. 2020. Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nat Rev Endocrinol 16:45-57. doi:10.1038/s41574-019-0273-8 PMID:31719706 PMCID:PMC6902641

2017

• Gasser E, Moutos CP, Downes M, Evans RM. 2017. FGF1-a new weapon to control type 2 diabetes mellitus. Nat Rev Endocrinol 13(10):599-609. doi:10.1038/nrendo.2017.78 PMID:28664920 PMCID:PMC5839646